Dipeptidyl peptidase-4 inhibitors and gallbladder or biliary disease in type 2 diabetes: systematic review and pairwise and network meta-analysis of randomised controlled trials.
Liyun HeJialu WangFan PingNa YangJingyue HuangWei LiLingling XuHuabing ZhangYu-Xiu LiPublished in: BMJ (Clinical research ed.) (2022)
PROSPERO CRD42021271647.